LPTN


Stock Update (NASDAQ:LPTN): Lpath, Inc. and Apollo Endosurgery Sign Merger Agreement

Lpath, Inc. (NASDAQ:LPTN) and Apollo Endosurgery, Inc.

Company Update (NASDAQ:LPTN): Lpath, Inc. Initiates First-in-Human Dosing in Phase 1 Clinical Trial of Lpathomab

Lpath, Inc. (NASDAQ:LPTN), the industry leader in bioactive lipid-targeted therapeutics, announced that the first cohort of six subjects has been dosed in the Phase 1 …

Lpath, Inc. (LPTN) Bullish Stance Reiterated at MLV

Lpath, Inc. (NASDAQ:LPTN) has been reiterated as a Buy at MLV by research analyst Arlinda Lee.

MLV Reiterates Buy On Lpath Following 3Q Earnings Update

In a research report sent to investors today, MLV analyst Arlinda Lee reiterated a Buy rating on Lpath Inc (NASDAQ:LPTN) with a $11 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts